Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indene SCHEMBL29350094 | 0.97 | — | — | |
| Indene SCHEMBL8617 | 0.97 | — | — | |
| Indene SCHEMBL8336138 | 0.97 | CA1 (0.55) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL7153004 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL8971559 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL23071394 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL1054910 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL8971580 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL23301011 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 | |
| Indene SCHEMBL6285027 | 0.95 | CA1 (0.53) | CA1CA2CYP2D6CYP2C19PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136675-A | Euphorbia lathyris spiro diterpenoid compound, preparation method thereof and application thereof in preventing and controlling plant fungal diseases | 江苏省中国科学院植物研究所 | 2025-06-13 | — | — | CN | disclosed |
| CN-120025253-A | Compounds useful as active compounds in organic electronic devices | 默克专利有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-111479811-B | Heterocyclic compounds for electronic devices | 默克专利有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-112739795-B | Compounds useful as active compounds in organic electronic devices | 默克专利有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-12035625-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| CN-112384595-B | Material for organic electroluminescent device | 默克专利有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-113195500-B | Material for organic electroluminescent device | 默克专利有限公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-3548481-B1 | HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-08-23 | — | — | EP | disclosed |
| EP-3548467-B1 | COMPOUNDS HAVING VALEROLACTAM STRUCTURES | MERCK PATENT GMBH (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-3880682-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-06-14 | — | — | EP | disclosed |
| WO-2002014536-A9 | ODULATING MULTIPLE LINEAGE KINASE PROTEINS | CEPHALON INC (US) | 2003-12-18 | — | — | WO | disclosed |
| EP-1309721-A2 | MODULATING MULTIPLE LINEAGE KINASE PROTEINS | CEPHALON, INC. (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6359130-B1 | ANTIBIOTIC, ANTITUMOR AGENT, ANTIINFLAMMATORY AGENT | CEPHALON, INC. | 2002-03-19 | — | — | US | disclosed |
| WO-2002014536-A2 | ODULATING MULTIPLE LINEAGE KINASE PROTEINS | CEPHALON, INC. (US) | 2002-02-21 | — | — | WO | disclosed |
| EP-1083903-A4 | BRIDGED INDENOPYRROLOCARBAZOLES | CEPHALON INC (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-1105728-A1 | MODULATING MULTIPLE LINEAGE KINASE PROTEINS | CEPHALON, INC. (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-1083903-A1 | BRIDGED INDENOPYRROLOCARBAZOLES | CEPHALON, INC. (US) | 2001-03-21 | — | — | EP | disclosed |
| US-6127401-A | TREATMENT OF PROSTATE DISORDERS, ANGIOGENIC DISORDERS, NEOPLASIA, RHEUMATOID ARTHRITIS, PULMONARY FIBROSIS, MYELOFIBROSIS, ABNORMAL WOUND HEALING, ATHEROSCLEROSIS, OR RESTENOSIS, ALZHEIMER'S DISEASE | CEPHALON, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| WO-2000013015-A1 | MODULATING MULTIPLE LINEAGE KINASE PROTEINS | CEPHALON, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-1999062523-A1 | BRIDGED INDENOPYRROLOCARBAZOLES | CEPHALON, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12035625-B2 | Materials for organic electroluminescent devices | ZYX, RER1, AOC2 | CA1 668/4885CA2 882/4885CYP2D6 3179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.